VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
KIDS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
KIDSOrthoPediatrics Corp.
$20.30$513M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksKIDSBalance Sheet

OrthoPediatrics Corp. (KIDS) Balance Sheet

12Y historyFree accessUpdated daily

The company's financial leverage has increased as total debt rose to $48.5M in 2026Q1, while the current ratio compressed to 5.21 from a peak of 7.40 in 2025Q3.

KIDS Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14
Total Current Assets245.87M256.42M237.17M226.5M226.72M133.65M158.43M128.06M97.16M69.56M20.83M22.47M27.51M
Cash & Short-Term Investments48.81M60.85M68.83M80.31M118.29M54.91M85.27M70.78M60.69M42.58M1.61M3.88M6.58M
Cash Only12.19M19.56M43.82M31.05M8.99M9.01M30.13M70.78M60.69M42.58M1.61M3.88M6.58M
Short-Term Investments36.62M41.3M25.01M49.25M109.3M45.9M55.14M000000
Accounts Receivable54.43M53.84M42.36M34.62M24.8M17.94M17.55M16.57M9.5M5.6M4.1M3.82M2.77M
Days Sales Outstanding80.0183.1475.5284.9574.0266.7990.1283.3560.2544.8340.144.9542.7
Inventory134.02M133.79M117M105.85M78.19M57.57M52.99M38M25.71M20.55M14.89M14.55M17.33M
Days Inventory Outstanding726.94766.77760.871.03K902.34852.581.21K773.43630.65671.35497.06566.96892.69
Other Current Assets8.61M7.94M1.96M5.72M1.47M3.23M2.62M1.25M0831K233K0577K
Total Non-Current Assets256.32M252.21M236.04M212.25M201.01M174.75M166.4M66.51M14.95M12.74M9.85M8.22M8.32M
Property, Plant & Equipment48.55M49.55M58.83M41.05M34.29M28.52M27.23M21.35M12.77M10.39M8.59M7.34M7.47M
Fixed Asset Turnover4.81x4.77x3.48x3.62x3.57x3.44x2.61x3.40x4.51x4.39x4.34x4.23x3.17x
Goodwill115.17M109.27M93.84M83.7M86.82M72.35M70.51M26.18M00000
Intangible Assets63.8M77.71M81.18M84.56M79.9M69.76M64.25M18.97M2.18M2.35M1.26M887K852K
Long-Term Investments002.18M1.85M189.52M0053.26M00000
Other Non-Current Assets28.8M15.68M01.08M-195.48M00-54.1M00000
Total Assets502.19M508.63M473.21M438.75M427.73M308.4M324.83M194.56M112.11M82.3M30.68M30.69M35.83M
Asset Turnover0.48x0.46x0.43x0.34x0.29x0.32x0.22x0.37x0.51x0.55x1.22x1.01x0.66x
Asset Growth %32.04%7.49%7.86%2.58%38.69%-5.06%66.95%73.56%36.21%168.29%-0.05%-14.34%-
Total Current Liabilities47.18M46.2M33.96M41.67M30.87M29.71M35.03M13.66M9.22M9.47M7.25M6.34M3.22M
Accounts Payable19.7M18.79M8.91M12.65M11.15M9.32M10.04M6.47M3.97M5.5M3.54M2M645K
Days Payables Outstanding81.26107.6757.93123.19128.67138.1228.32131.6397.41179.56118.3177.8933.23
Short-Term Debt172K170K160K152K144K13M12.36M124K118K113K107K101K97K
Deferred Revenue (Current)00005.95M004.35M3.55M2.9M2.22M2.26M1.48M
Other Current Liabilities27.31M16.64M8.89M7.39M6.88M2.04M8.09M-1.63M1.58M954K1.38M1.98M992K
Current Ratio5.21x5.55x6.98x5.44x7.34x4.50x4.52x9.37x10.54x7.35x2.87x3.55x8.55x
Quick Ratio2.37x2.65x3.54x2.90x4.81x2.56x3.01x6.59x7.75x5.18x0.82x1.25x3.16x
Cash Conversion Cycle725.69742.25778.46992.63847.69781.271.07K725.15593.48536.61418.86534.02902.17
Total Non-Current Liabilities69.11M115.84M84.68M20.05M18.21M53.32M55.03M38.54M21.16M25.34M17.43M13.04M14.63M
Long-Term Debt48.31M99.82M72.96M9.91M763K15.22M13.83M26.07M21.16M25.34M17.43M13.04M13.14M
Capital Lease Obligations005.66M00293K323K63K00000
Deferred Tax Liabilities14.27M3.58M05.48M5.95M8.9M10.17M-63K00000
Other Non-Current Liabilities17.45M12.44M6.06M4.66M11.49M28.91M30.71M000001.49M
Total Liabilities116.3M162.03M118.64M61.72M49.08M83.03M90.06M52.2M30.37M34.81M24.68M19.38M17.85M
Total Debt48.48M99.99M80.9M10.06M907K28.51M26.52M26.25M21.27M25.45M17.54M13.14M13.24M
Net Debt36.29M80.43M37.08M-21M-8.08M19.5M-3.62M-44.52M-39.42M-17.13M15.93M9.26M6.66M
Debt / Equity0.14x0.29x0.23x0.03x0.00x0.13x0.11x0.18x0.26x0.54x2.93x1.16x0.74x
Debt / EBITDA-3.65x------------
Net Debt / EBITDA-2.73x------------
Interest Coverage-5.55x-4.86x-11.26x--8.99x-7.95x-8.87x-2.59x-4.33x-2.59x-3.45x-5.38x-2.83x
Total Equity338.71M346.6M354.57M377.02M378.65M225.37M234.77M142.36M81.73M47.49M5.99M11.31M17.98M
Equity Growth %-14.75%-2.25%-5.96%-0.43%68.01%-4%64.91%74.18%72.09%692.38%-47.03%-37.06%-
Book Value per Share14.3014.7715.3616.6318.0811.7013.009.736.509.860.801.512.42
Total Shareholders' Equity338.71M346.6M354.57M377.02M378.65M225.37M234.77M142.36M81.73M47.49M5.99M11.31M17.98M
Common Stock6K6K6K6K6K5K5K4K4K2K1K1K1K
Retained Earnings-285.9M-275.21M-235.56M-197.74M-176.77M-178.03M-161.77M-128.82M-115.09M-103.07M-78.13M-71.56M-63.67M
Treasury Stock0000000000000
Accumulated OCI-1.4M-523K-10.77M-5.53M-5.4M8.49M7.91M-3K-623K135K0-6.24M-4.43M
Minority Interest0000000000000

Key Metrics

Growth RegimeDecelerating
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Liquidity and capital constraints

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Capital Erosion Amidst Operational Losses

According to recent quarterly filings, OrthoPediatrics has seen its cash position dwindle from $44.6M in 2025Q2 to $12.2M by 2026Q1, signaling a weakening balance sheet trajectory as the company struggles to bridge the gap between its heavy capital intensity and its persistent net losses.

The consistent accumulation of retained earnings deficits, now totaling -$285.9M, underscores a long-term trend of value destruction that has not yet been offset by revenue growth. Investors should monitor whether the current trajectory of asset growth can be sustained without further dilutive equity raises or increased debt reliance.

Rising Leverage Amidst Cash Constraints

As reported in financial statements, the company's debt load has increased significantly from $10.1M in 2023Q4 to $48.5M in 2026Q1, pushing the debt-to-equity ratio to 0.14 and suggesting a shift toward debt financing to support ongoing operations as internal cash generation remains elusive.

While the current leverage remains manageable in absolute terms, the rapid escalation in debt levels during a period of negative operating margins warrants caution. This reliance on debt may indicate that the company is exhausting its internal liquidity buffers and may face higher interest costs if refinancing becomes necessary.

Capital Intensity of Instrument Placements

Based on reported figures, the company's asset base is heavily weighted toward PPE and goodwill, with net PPE reaching $48.6M in 2026Q1, reflecting the significant upfront capital investment required to place surgical instrument sets in hospitals to drive future recurring revenue pull-through.

The high concentration of assets in specialized surgical kits creates a rigid cost structure that limits balance sheet flexibility. Because these assets are non-liquid and require ongoing maintenance, the company's ability to pivot its capital allocation strategy appears constrained by the necessity of supporting its existing installed base.

Diminishing Buffer Against Operational Burn

As indicated by the most recent quarterly data, the current ratio has compressed from a peak of 7.40 in 2025Q3 to 5.21 in 2026Q1, highlighting a tightening liquidity position that leaves the company with less of a buffer against unexpected shocks or prolonged operational cash burn.

While the current ratio remains technically healthy, the absolute decline in cash reserves is the more critical metric for investors to track. The company's reliance on cash to fund its growth initiatives suggests that liquidity could become a primary constraint if the current burn rate is not moderated.

KIDS — Frequently Asked Questions

Quick answers to the most common questions about buying KIDS stock.

What are the total assets of OrthoPediatrics Corp. (KIDS)?

As of 2025, OrthoPediatrics Corp. (KIDS) had total assets of $508.6M including $256.4M in current assets.

How much debt does OrthoPediatrics Corp. (KIDS) have?

OrthoPediatrics Corp. (KIDS) carries total debt of $100.0M, offset by $60.9M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of OrthoPediatrics Corp.?

OrthoPediatrics Corp. (KIDS) has total shareholders' equity (book value) of $346.6M ($14.77 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is OrthoPediatrics Corp.'s current ratio and liquidity?

OrthoPediatrics Corp. (KIDS) reported a current ratio of 5.55x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.